Surgery Partners cuts 2026 revenue outlook
- Surgery Partners (NASDAQ:SGRY) updated its 2026 outlook after completing the sale of its Idaho Falls facilities to Intermountain Health.
- The company expects 2026 revenue of $3.08 billion to $3.18 billion and adjusted EBITDA of at least $489 million.
- The transaction generated $797 million in gross proceeds, with proceeds mainly targeted toward debt reduction.
Surgery Partners (NASDAQ:SGRY) updated its 2026 financial outlook following the completed sale of its Idaho Falls facilities to Intermountain Health.
The company now expects 2026 revenue between $3.08 billion and $3.18 billion, with adjusted EBITDA expected to be at least $489 million, reflecting the removal of Idaho Falls operations from the remaining-year outlook.
On a full-year pro forma basis excluding Idaho Falls, Surgery Partners expects revenue of approximately $2.6 billion to $2.67 billion and adjusted EBITDA of at least $414 million, while the transaction generated $797 million in gross proceeds and $587 million in net cash proceeds.
Surgery Partners operates surgical facilities and healthcare services businesses, including ambulatory surgery centers and related healthcare delivery platforms.
The company expects leverage under its credit agreement to improve by 30 basis points from 4.4x at the end of the second quarter of 2026 following the transaction and debt reduction actions.
